Nightingale successfully completes the first phase of its at-home blood testing pilot
Company Release 23 June 2021 at 9:30 a.m. (Finnish time) Nightingale Health Oyj (“Nightingale”) announced in February 2021 an early-access pilot of its at-home blood testing solution for 10,000 consumers in Finland. As planned, the first phase of the pilot began in the second quarter of 2021 by providing consumers the opportunity to be the first users of Nightingale’s at-home testing solution. After opening registration, the at-home blood collection kit orders exceeded quickly the maximum number of participants for the first phase, and blood samples collected at home were shipped